Previous close | 3.4400 |
Open | 3.4600 |
Bid | 3.4600 x 2900 |
Ask | 3.5100 x 800 |
Day's range | 3.4500 - 3.6000 |
52-week range | 0.8200 - 5.9900 |
Volume | |
Avg. volume | 364,553 |
Market cap | 75.993M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Director Ngar Louie has recently increased his stake in MAIA Biotechnology Inc (AMEX:MAIA) by purchasing 170,940 shares of the company's stock, according to a SEC Filing dated March 14, 2024.
MAIA Biotechnology (MAIA) reports updated results from a mid-stage study. Patients treated with its lead drug achieved disease control rates that were well-sustained compared with previous scans.
MAIA Biotechnology, Inc. (MAIA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.